|
Profile
|
Delegates :
Kentaro Yano |
|
Incorporated :
December 27 , 2023 |
Paid in Capital :
1 Million yen |
Employees :
人 |
Address :
Mukaibara 3-15-7, Asouku, Kawasaki-si KANAGAWA
〒215-0007
|
TEL/FAX :
/ |
URL：
https://www.wellgreen-i.com |
Attachment :
|
Mission/Background :
Wellgreen-i Inc. (WGI) quickly responds to on-site needs in information collection and analysis. Using proprietary AI text-mining, we extract target data from large-scale texts in economics, policy, patents, drug discovery, and breeding, and conduct contract analyses of omics and life science big data, including gene exploration. With over 30 years of advanced R&D experience, WGI provides clear gene function data, detailed expression conditions, accurate gene family information, and AI-based predictions of cis- and transcription factors. These support rapid identification of trait-related genes and metabolites, and optimal gRNA design for multiplex genome editing. By combining proprietary big data with AI and DX technologies, WGI advances research and business development beyond conventional methods, accelerating R&D, strategy, and knowledge creation. We also support bioinformatics training and system setup. |
|
Technology & Business
|
Information gathering from big data:
Our proprietary AI text-mining technologies, A2K and LA2K, quickly and accurately extract target information from large-scale literature. LA2K, specialized for life sciences, automatically integrates gene-related data from publications.
High-precision multi-omics analysis:
Using public RNA-Seq and other data, we clarify gene expression across time, space, and conditions to accelerate identification of trait-related genes. Our AI-based DNA analysis predicts transcription and cis-regulatory factors with high accuracy. Precise inter- and intra-species gene families enable cross-species reference of gene functions, supporting gene discovery even in poorly studied organisms. We also design optimal gRNAs for efficient multiplex genome editing.
We offer cost-effective bioinformatics solutions, including data analysis, research planning, system setup, bottleneck resolution, training, and DB/LIMS/FIMS construction.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
A2K
|
Launched
|
AI-driven text mining of large-scale online information and electronic files
|
Acquisition of customers, improvement of performance, development of domestic and overseas sales channels
|
LA2K
|
Launched
|
AI-driven life science text mining enables precise extraction of target and gene-related information
|
Acquisition of customers, improvement of performance, development of domestic and overseas sales channels
|
Identifying trait-related genes and elucidating their functions
|
Launched
|
High-quality gene expression big data clarify gene expression patterns, accelerating trait gene identification
|
Acquisition of customers, improvement of performance, development of domestic and overseas sales channels
|
Highly accurate prediction of transcription factors and cis-factors using AI-driven DNA sequence analysis
|
Launched
|
Comprehensive and highly accurate prediction of transcription factors that bind to cis-factors in the genome
|
Acquisition of customers, improvement of performance, development of domestic and overseas sales channels
|
Various bioinformatics support
|
Launched
|
gRNA design for efficient genome editing genome/gene analysis, R&D planning, training, and system implementation
|
Acquisition of customers, development of domestic and overseas sales channels
|
|
Highlights
|
In order to develop overseas sales channels, we have completed negotiations with a Chinese distributor and are planning to sign a contract.
|
|
Hot news
|
The CEO is a top researcher with over 30 years of experience in academia, conducting research and development in areas such as genome and gene analysis, database and knowledge base construction, and AI text mining, and has a wealth of experience and a proven track record in cutting-edge technology development and digital information analysis.
|
|
Alliance strategy
|
We are seeking collaborations with universities and companies in the fields of human and animal genomic medicine and drug discovery, plant and animal breeding, biomanufacturing, and GX, among others, in joint research and technology development utilizing plant transomics analysis technology.
|
|
|